(MedPage Today) — Liver transplant recipients treated with a GLP-1 receptor agonist experienced a lower risk of death compared with those not receiving a GLP-1 medication, according to a retrospective three-center cohort study.
Among 2,402 patients, those on GLP-1 receptor agonists…
